Audit 391892

FY End
2025-09-30
Total Expended
$6.10M
Findings
29
Programs
9
Year: 2025 Accepted: 2026-03-14
Auditor: CBIZ CPAS PC

Organization Exclusion Status:

Checking exclusion status...

Findings

ID Ref Severity Repeat Requirement
1179489 2025-001 Material Weakness Yes AB
1179490 2025-001 Material Weakness Yes AB
1179491 2025-001 Material Weakness Yes AB
1179492 2025-001 Material Weakness Yes AB
1179493 2025-001 Material Weakness Yes AB
1179494 2025-001 Material Weakness Yes AB
1179495 2025-001 Material Weakness Yes AB
1179496 2025-001 Material Weakness Yes AB
1179497 2025-001 Material Weakness Yes AB
1179498 2025-001 Material Weakness Yes AB
1179499 2025-001 Material Weakness Yes AB
1179500 2025-001 Material Weakness Yes AB
1179501 2025-001 Material Weakness Yes AB
1179502 2025-001 Material Weakness Yes AB
1179503 2025-001 Material Weakness Yes AB
1179504 2025-001 Material Weakness Yes AB
1179505 2025-001 Material Weakness Yes AB
1179506 2025-001 Material Weakness Yes AB
1179507 2025-001 Material Weakness Yes AB
1179508 2025-001 Material Weakness Yes AB
1179509 2025-001 Material Weakness Yes AB
1179510 2025-001 Material Weakness Yes AB
1179511 2025-001 Material Weakness Yes AB
1179512 2025-001 Material Weakness Yes AB
1179513 2025-001 Material Weakness Yes AB
1179514 2025-001 Material Weakness Yes AB
1179515 2025-001 Material Weakness Yes AB
1179516 2025-001 Material Weakness Yes AB
1179517 2025-001 Material Weakness Yes AB

Programs

ALN Program Spent Major Findings
93.838 LUNG DISEASES RESEARCH $99,217 Yes 1
47.084 NSF TECHNOLOGY, INNOVATION, AND PARTNERSHIPS $81,720 Yes 1
93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH $81,512 Yes 1
93.859 BIOMEDICAL RESEARCH AND RESEARCH TRAINING $30,822 Yes 1
93.866 AGING RESEARCH $20,775 Yes 1
93.837 CARDIOVASCULAR DISEASES RESEARCH $19,705 Yes 1
93.395 CANCER TREATMENT RESEARCH $5,544 Yes 1
12.420 MILITARY MEDICAL RESEARCH AND DEVELOPMENT $2,847 Yes 1
93.242 MENTAL HEALTH RESEARCH GRANTS $2,529 Yes 1

Contacts

Name Title Type
YZWJABL7PW69 Corey Coia Auditee
4012737100 Erica Olobri Auditor
No contacts on file

Notes to SEFA

The accompanying Schedule of Expenditures of Federal Awards (Schedule) includes the federal award activity of the Ocean State Research Institute, Inc. (OSRI) under programs of the federal government for the year ended September 30, 2025. The information in this Schedule is presented in accordance with the requirements of Title 2 U.S. Code of Federal Regulations Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (Uniform Guidance). Because the Schedule presents only a selected portion of the operations of OSRI, it is not intended to and does not present the financial position, changes in net assets, or cash flows of OSRI.
1. Expenditures reported on the Schedule are reported on the accrual basis of accounting. Such expenditures are recognized following the cost principles contained in the Uniform Guidance, wherein certain types of expenditures are not allowable or are limited as to reimbursement. 2. OSRI has elected not to use the 10 percent de minimis indirect cost rate as allowed under the Uniform Guidance.
In accordance with the requirements of Title 2 U.S. Code of Federal Regulations Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (Uniform Guidance), certain programs have been clustered in determining major programs. All of OSRI’s programs are included as one research and development cluster.

Finding Details

CRITERIA: Per 2 CFR 200.405 and the grant agreement, costs charged to federal awards must be allowable, allocable, and in accordance with the approved indirect cost rate agreement. CONDITION: The entity overcharged indirect costs to the federal award by $1,462 during the year ended September 30, 2025. CAUSE: The entity applied the incorrect indirect cost rate. EFFECT: Overcharging indirect costs reduces costs available for the program and hinders program administration. QUESTIONED COSTS: $1,462 CONTEXT: This error was found in AL #47.084 which was $81,720 of expenses included in the total of $6,097,828 of federal expenditures. Total indirect costs of $906,416 were tested during the period out of which $1,462 were misapplied. PRIOR YEAR FINDING: No RECOMMENDATION: We recommend the entity review and update its grant management procedures to ensure the correct indirect cost rate is applied to all federal awards and that staff are trained on the current rates in effect. VIEWS OF RESPONSIBLE OFFICIALS AND PLANNED CORRECTIVE ACTION: Please see management’s Corrective Action Plan included in this reporting package.